Company intelligence / Profile preview
Shenzhen Eglin Pharmaceutical
Shenzhen, Guangdong, Chinaegpharm.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Shenzhen Eglin Pharmaceutical is a clinical-stage pharmaceutical company with a pipeline focused on small molecules and antibodies for endocrine, metabolic, nervous system, neoplastic, immune system, infectious diseases, and ophthalmic indications. Lead assets are in late-stage clinical development for oncology and ophthalmology.
- Therapeutic areas
- OphthalmologyImmunologyEndocrinologyOncology
- Modalities
- Small moleculeMonoclonal antibodyAntibody
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Evergreen Therapeutics Inc.
Beyond the preview
Go deeper on Shenzhen Eglin Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen Eglin Pharmaceutical.